MDWD
Mediwound LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$213.09M
P/E Ratio
—
EPS
$-2.10
Beta
0.22
52W High
$22.50
52W Low
$14.90
50-Day MA
$16.80
200-Day MA
$17.62
Dividend Yield
—
Profit Margin
-140.80%
Forward P/E
34.97
PEG Ratio
-0.07
About Mediwound Ltd
MediWound Ltd., a biopharmaceutical company, develops, manufactures and markets new and biotherapeutic solutions for tissue repair and regeneration. The company is headquartered in Yavne, Israel.
Fundamentals
| Revenue (TTM) | $16.96M |
| Gross Profit (TTM) | $3.25M |
| EBITDA | $-24.28M |
| Operating Margin | -417.80% |
| Return on Equity | -63.90% |
| Return on Assets | -19.80% |
| Revenue/Share (TTM) | $1.49 |
| Book Value | $3.40 |
| Price-to-Book | 4.88 |
| Price-to-Sales (TTM) | 12.56 |
| EV/Revenue | 9.91 |
| EV/EBITDA | -6.32 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -68.00% |
| Shares Outstanding | $12.85M |
| Float | $8.89M |
| % Insiders | 15.86% |
| % Institutions | 58.24% |
Historical Volatility
HV 10-Day
28.16%
HV 20-Day
30.06%
HV 30-Day
33.16%
HV 60-Day
37.97%
HV Rank
12.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($31.33 target)
1
Strong Buy5
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026